Response to the comments to the Editor regarding "Denosumab for the management of central giant cell granuloma of the jaws-a case series"
Int J Oral Maxillofac Surg
.
2022 Jun;51(6):845.
doi: 10.1016/j.ijom.2021.09.013.
Epub 2021 Oct 23.
Author
M A Pogrel
1
Affiliation
1
Department of Oral and Maxillofacial Surgery, University of California, San Francisco, CA, USA. Electronic address: tony.pogrel@ucsf.edu.
PMID:
34696943
DOI:
10.1016/j.ijom.2021.09.013
No abstract available
Publication types
Letter
Comment
MeSH terms
Bone Density Conservation Agents*
Denosumab / therapeutic use
Granuloma, Giant Cell* / diagnostic imaging
Granuloma, Giant Cell* / drug therapy
Humans
Jaw
Substances
Bone Density Conservation Agents
Denosumab